- Home
- GVH vs MBIO Comparison
GVH vs MBIO Comparison
Compare GVH & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GVH
- MBIO
- Stock Information
- Founded
- GVH 2016
- MBIO 2015
- Country
- GVH Australia
- MBIO United States
- Employees
- GVH N/A
- MBIO N/A
- Industry
- GVH
- MBIO Biotechnology: Pharmaceutical Preparations
- Sector
- GVH
- MBIO Health Care
- Exchange
- GVH Nasdaq
- MBIO Nasdaq
- Market Cap
- GVH 7.4M
- MBIO 7.3M
- IPO Year
- GVH 2023
- MBIO N/A
- Fundamental
- Price
- GVH $0.49
- MBIO $1.24
- Analyst Decision
- GVH
- MBIO Strong Buy
- Analyst Count
- GVH 0
- MBIO 1
- Target Price
- GVH N/A
- MBIO $100.00
- AVG Volume (30 Days)
- GVH 123.4K
- MBIO 972.6K
- Earning Date
- GVH 02-12-2025
- MBIO 05-14-2025
- Dividend Yield
- GVH N/A
- MBIO N/A
- EPS Growth
- GVH 12.04
- MBIO N/A
- EPS
- GVH 0.09
- MBIO N/A
- Revenue
- GVH $16,540,178.00
- MBIO N/A
- Revenue This Year
- GVH N/A
- MBIO N/A
- Revenue Next Year
- GVH N/A
- MBIO N/A
- P/E Ratio
- GVH $5.22
- MBIO N/A
- Revenue Growth
- GVH N/A
- MBIO N/A
- 52 Week Low
- GVH $0.47
- MBIO $1.13
- 52 Week High
- GVH $2.57
- MBIO $65.00
- Technical
- Relative Strength Index (RSI)
- GVH 36.55
- MBIO 36.60
- Support Level
- GVH $0.49
- MBIO $1.13
- Resistance Level
- GVH $0.50
- MBIO $1.38
- Average True Range (ATR)
- GVH 0.04
- MBIO 0.12
- MACD
- GVH 0.00
- MBIO 0.05
- Stochastic Oscillator
- GVH 14.73
- MBIO 37.93
About GVH Globavend Holdings Limited
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.